Opus Genetics Inc. (IRD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Opus Genetics Inc.

    NASDAQ: IRD · Real-Time Price · USD
    1.29
    0.02 (1.57%)
    At close: Sep 08, 2025, 10:12 AM

    Opus Genetics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 10.99M 19.05M 39.85M 589K
    Cost of Revenue
    		 10K 6K 4K 4K
    Gross Profit
    		 10.98M 19.05M 39.85M 589K
    Operating Income
    		 -62.07M -10.56M 18.23M -22.7M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -57.53M -9.97M 18.2M -56.69M
    Net Income
    		 -57.53M -9.99M 17.89M -56.69M
    Selling & General & Admin
    		 18.21M 11.96M 7.27M 8.12M
    Research & Development
    		 26.85M 17.65M 14.36M 15.17M
    Other Expenses
    		 28M n/a n/a n/a
    Operating Expenses
    		 73.07M 29.61M 21.62M 23.29M
    Interest Expense
    		 n/a 1.33M 9K 2K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 73.07M 29.61M 21.62M 23.29M
    Income Tax Expense
    		 n/a 12K 315K n/a
    Shares Outstanding (Basic)
    		 26.72M 21.59M 19.93M 14.85M
    Shares Outstanding (Diluted)
    		 26.72M 21.59M 20.6M 14.85M
    EPS (Basic)
    		 -2.15 -0.46 0.90 -3.82
    EPS (Diluted)
    		 -2.15 -0.46 0.87 -3.82
    EBITDA
    		 -57.52M -9.97M 18.22M -56.69M
    EBIT
    		 -57.53M -9.97M 18.21M -56.69M
    Depreciation & Amortization
    		 10K 6K 4K 4K

    Add to Watchlist